Business Segments · Cost of products sold
Interventional — Cost of products sold
Becton, Dickinson and Company Interventional — Cost of products sold decreased by 3.6% to $429.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 7.0%, from $401.00M to $429.00M. This is a positive signal — lower values indicate better performance for this metric.
Analysis
StatementSegment
CategoryProfitability
SignalLower is better
VolatilityStable
Rolls up toTotal Cost of Revenue
How to read this metric
An increase relative to revenue suggests margin compression, while a decrease relative to revenue suggests improved manufacturing efficiency or lower input costs.
Detailed definition
This metric captures the direct costs associated with manufacturing and delivering the products sold within the Interven...
Peer comparison
Standard cost of goods sold (COGS) metric for specific business units across the medical device industry.
Metric ID:
bdx_segment_interventional_cost_of_products_soldHistorical Data
12 periods
| Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $412.50M | $412.50M | $412.50M | $412.50M | $423.25M | $423.25M | $423.25M | $423.25M | $404.00M | $401.00M | $445.00M | $429.00M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +2.6% | +0.0% | +0.0% | +0.0% | -4.5% | -0.7% | +11.0% | -3.6% |
| YoY Change | — | — | — | — | +2.6% | +2.6% | +2.6% | +2.6% | -4.5% | -5.3% | +10.1% | +7.0% |
Range$401.00M – $445.00M
CAGR+1.4%
Avg YoY Growth+2.2%
Median YoY Growth+2.6%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Becton, Dickinson and Company's interventional — cost of products sold?
- Becton, Dickinson and Company (BDX) reported interventional — cost of products sold of $429.00M in Q1 2026.
- How has Becton, Dickinson and Company's interventional — cost of products sold changed year-over-year?
- Becton, Dickinson and Company's interventional — cost of products sold increased by 7.0% year-over-year, from $401.00M to $429.00M.
- What does interventional — cost of products sold mean?
- The direct costs incurred to produce and deliver goods sold by the Interventional segment.